IKZF1 and colorectal carcinoma: Further, a plasma specimen with 100 pg of methylated IKZF1 DNA is approximately 2.5 times more likely to be drawn from a subject with late stage CRC (Stage III or IV) than a subject with early stage CRC (Stage I or II).